ArticleArthroscopy techniques2025
Arthroscopic Supraspinatus Tendon Reconstruction Using Fascia Lata Autograft Augmentation for Type B and C Musculotendinous Junction Tears.
Article in Arthroscopy techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type B and C musculotendinous junction tears present unique surgical challenges because of poor tissue integrity. We describe an arthroscopic technique-the supraspinatus tendon reinforcement reconstruction technique-that combines autologous fascia lata grafting with remnant tendon augmentation. This biologically optimized approach achieves anatomic restoration through 3 key principles: intramuscular fascia lata passage to enhance medial integration, lateral bridging reinforcement fixation to improve load distribution, and scapular spine anchoring for structural stability. By preserving native kinematics while augmenting repair integrity, this reproducible method may reduce retear rates in type B and C musculotendinous junction tears, offering a viable alternative to traditional reconstructions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.